Market Closed -
Other stock markets
|
Pre-market 12:32:31 | |||
15.15 USD | -3.50% | 15.34 | +1.29% |
05-23 | B. Riley Boosts Price Target on Novavax to $29 From $11, Maintains Buy Rating | MT |
05-21 | Novavax: 1st shipment of R21/MatrixM malaria vaccine | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+215.62% | 2.13B | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.26% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi